E84 Cystic fibrosis

Name of the Condition

• Cystic Fibrosis (ICD-10 Code: E84)

Summary

Cystic fibrosis is a genetic disorder that affects multiple organ systems, primarily the lungs and digestive tract. It is characterized by the production of thick, sticky mucus that can clog airways and obstruct pancreatic ducts, leading to respiratory and nutritional complications. The condition is progressive and requires lifelong management to address symptoms and slow disease progression.

Causes

Cystic fibrosis is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which regulates the movement of salt and water in and out of cells. These mutations result in defective CFTR protein function, leading to abnormal mucus production. The disorder follows an autosomal recessive inheritance pattern, meaning an individual must inherit two copies of the mutated gene (one from each parent) to develop the condition.

Risk Factors

• Family history of cystic fibrosis.
• Being of Northern European descent (higher prevalence).
• Carrying one copy of the CFTR mutation (carrier status).

Symptoms

• Persistent cough with thick mucus.
• Frequent lung infections (e.g., pneumonia, bronchitis).
• Wheezing or shortness of breath.
• Poor weight gain or growth despite adequate nutrition.
• Greasy, bulky stools or difficulty with bowel movements.
• Salty-tasting skin.

Diagnosis

Diagnosis typically involves a combination of newborn screening, sweat chloride testing (to measure salt levels in sweat), and genetic testing for CFTR mutations. Additional tests, such as lung function assessments or imaging, may be used to evaluate organ involvement. A confirmed diagnosis requires abnormal sweat chloride levels and/or two identified CFTR mutations.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. This may include airway clearance techniques, inhaled medications to thin mucus, antibiotics for infections, pancreatic enzyme supplements, and nutritional support. Lung transplantation may be considered in advanced cases. Regular monitoring by a multidisciplinary team is essential.

Prognosis and Follow-Up

Prognosis has improved with advances in care, but cystic fibrosis remains a life-limiting condition. Life expectancy varies based on disease severity and access to treatment. Regular follow-up with pulmonologists, gastroenterologists, and other specialists is critical to address respiratory, nutritional, and other health needs. Early intervention can help maintain quality of life.

Complications

• Chronic lung infections and respiratory failure.
• Malnutrition or poor growth due to pancreatic insufficiency.
• Diabetes (cystic fibrosis-related diabetes).
• Liver disease (e.g., cirrhosis).
• Infertility (particularly in males).

Lifestyle & Prevention

While cystic fibrosis cannot be prevented, lifestyle measures can support management. These include maintaining a high-calorie, high-fat diet, staying up-to-date on vaccinations, avoiding smoke and pollutants, and practicing good hygiene to reduce infection risk. Regular exercise may also help improve lung function.

When to Seek Professional Help

Seek medical attention if experiencing worsening respiratory symptoms (e.g., increased cough, shortness of breath), unexplained weight loss, persistent digestive issues, or signs of infection (e.g., fever, fatigue). Prompt care is important to address acute complications and adjust treatment plans.

Tips for Medical Coders

When coding for cystic fibrosis (E84), ensure documentation supports the diagnosis, including clinical findings, genetic testing results, or sweat chloride test values. Note any associated complications (e.g., respiratory infections, pancreatic insufficiency) as they may require additional codes. Verify that the code aligns with the patient’s specific manifestations and clinical course.